サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1654678

側副靭帯スタビライザーシステムの世界市場：2025年～2033年

Global Collateral Ligament Stabilizer System Market - 2025-2033

出版日
ページ情報
英文 210 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.08円
側副靭帯スタビライザーシステムの世界市場：2025年～2033年
出版日: 2025年02月13日
発行: DataM Intelligence
ページ情報: 英文 210 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

側副靭帯スタビライザーシステムの世界市場は、2024年に23億2,000万米ドルに達し、2033年までには41億1,000万米ドルに達し、予測期間中の2025年から2033年にはCAGR6.5%で成長すると予測されています。

側副靭帯スタビライザーシステムは、主に膝関節の側副靭帯の損傷や弱化をサポートし、安定性とアライメントを整えるために設計された特殊な医療機器です。内側側副靭帯（MCL）や外側側副靭帯（LCL）を含むこれらの靭帯は、過度な左右の動きを防ぐことで関節の安定性を維持するという重要な役割を担っています。これらの靭帯の損傷は、スポーツ関連活動、事故、または変性疾患によるものが一般的で、痛み、腫れ、関節の不安定性につながります。

市場力学：

促進要因と抑制要因

スポーツ関連傷害の増加

側副靭帯スタビライザーシステム市場は、世界のスポーツ関連傷害の増加、特に膝の増加により成長しています。サッカー、バスケットボール、スキー、ラグビーなどの衝撃の大きいスポーツは、急激な方向転換や身体接触を伴うため、アスリートは影響を受けやすいです。フィットネス動向や競合スポーツの人気は、靭帯関連傷害のリスクをさらに高めています。このため、より早い回復、関節の安定性、アスリートの再負傷リスクの低減を支援する高度なスタビライザーシステムに対する需要が高まっています。

例えば、日本の大学スポーツ選手のスポーツ傷害の有病率は高く、半数が傷害を報告し、45％が複数の傷害を負っています。この割合は、諸外国の一般集団やスポーツ集団で報告されている数値を上回っています。ドイツでは、成人の3.1％が過去1年間にスポーツ外傷を負ったと報告し、デンマークでは成人の18.4％、子どもの19.3％が過去12ヶ月以内にスポーツ外傷を負ったと報告しています。フィンランドの青少年は、過去1年間に少なくとも1回の急性または使いすぎによる傷害を報告しました。ブラジルのアスリートは、本研究のアスリートのように1年以内ではなく、医学研究の6年間から10年間で49％の傷害有病率を報告しています。

新興地域における認知度の低さと診断の遅れ

側副靭帯スタビライザーシステム市場は、特に新興地域や低開発地域において、靭帯損傷の認知度の低さと診断の遅れによる課題に直面しています。地方の人々は損傷の深刻さを認識できなかったり、症状を軽度の歪みと判断したりするため、適切な医療措置を受けるのが遅れます。専門的な整形外科医療や診断施設へのアクセス不足は、さらに過小診断や過小治療の一因となり、スタビライザーシステムに対する需要を低下させ、市場成長の妨げとなっています。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • スポーツ関連の傷害の増加
    • 抑制要因
      • 新興地域での認識不足と診断の遅れ
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析

第6章 靭帯タイプ別

  • 内側側副靭帯（MCL）
  • 外側側副靭帯（LCL）

第7章 傷害タイプ別

  • グレードI（軽度）
  • グレードII（中程度）
  • グレードIII（重度）

第8章 エンドユーザー別

  • 病院
  • 整形外科クリニック
  • その他

第9章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他欧州地域
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋
  • 中東・アフリカ

第10章 競合情勢

  • 競合シナリオ
  • 市況・シェア分析
  • M&A分析

第11章 企業プロファイル

  • Bauerfeind.
    • 会社概要
    • 製品ポートフォリオ
      • 製品説明
      • 製品の主要業績評価指標（KPI）
      • 過去および予測の製品販売
      • 製品販売量
    • 財務概要
      • 会社の収益
      • 地域別収益分配
      • 収益予測
    • 主な発展
      • 合併と買収
      • 主な製品開発活動
      • 規制当局の承認等
    • SWOT分析
  • Enovis（DJO Global, Inc.）
  • DeRoyal Industries
  • Ossur hf.
  • DARCO International, Inc.
  • Orthofix US LLC（Breg, Inc.）
  • Thuasne USA
  • Bio Dynamic Technologies
  • BSN Medical
  • Breg, Inc
    • パイプライン製品の説明
    • 製品の主要業績評価指標（KPI）
    • 主な活動
    • 市場参入のタイムライン
    • 製品普及率
    • 売上予測と予測
  • Corin Group
  • 各市場参入企業に対しても同様のデータが提供されます。

第12章 付録

目次
Product Code: MD9128

The Global Collateral Ligament Stabilizer System Market reached US$ 2.32 Billion in 2024 and is expected to reach US$ 4.11 Billion by 2033, growing at a CAGR of 6.5% during the forecast period 2025-2033.

The Collateral Ligament Stabilizer System is a specialized medical device designed to provide support, stability, and alignment to injured or weakened collateral ligaments, primarily in the knee joint. These ligaments, including the medial collateral ligament (MCL) and lateral collateral ligament (LCL), play a crucial role in maintaining the joint's stability by preventing excessive side-to-side movements. Injuries to these ligaments are common in sports-related activities, accidents, or due to degenerative conditions, leading to pain, swelling, and joint instability.

Market Dynamics: Drivers & Restraints

Increasing Prevalence of Sports-related Injuries

The Collateral Ligament Stabilizer System market is growing due to the rise in sports-related injuries globally, particularly in knees. High-impact sports like football, basketball, skiing, and rugby involve rapid directional changes and physical contact, making athletes susceptible. The popularity of fitness trends and competitive sports has further increased the risk of ligament-related injuries. This has driven the demand for advanced stabilizer systems that aid in faster recovery, joint stability, and reduced risk of reinjury in athletes.

For instance, The prevalence of sports injuries among Japanese collegiate athletes is high, with half reporting an injury and 45% sustaining multiple injuries. This rate exceeds numbers reported for general and sports populations in other countries. In Germany, 3.1% of adults reported sustaining a sports injury in the previous year, while in Denmark, 18.4% of adults and 19.3% of children reported having a sports injury within the past 12 months. Finnish adolescents reported at least one acute or overuse injury in the previous year. Brazilian athletes reported an injury prevalence of 49% over 6-10 years of their medical studies, not within a year like the athletes in the current study.

Limited Awareness and Delayed Diagnosis in Emerging Regions

The collateral ligament stabilizer system market faces challenges due to limited awareness and delayed diagnosis of ligament injuries, particularly in emerging and underdeveloped regions. Rural individuals may not recognize the severity of injuries or attribute symptoms to minor strains, leading to delays in seeking proper medical attention. Lack of access to specialized orthopedic care and diagnostic facilities further contributes to underdiagnosis and undertreatment, reducing demand for stabilizer systems and hindering market growth.

Segment Analysis

The global Collateral Ligament Stabilizer System market is segmented based on, Ligament Type, Injury Type, End User and Region.

Ligament Type:

Medial Collateral Ligament (MCL) segment is expected to dominate the Collateral Ligament Stabilizer System market share

The medial collateral ligament (MCL) segment holds a major portion of the Collateral Ligament Stabilizer System market share and is expected to continue to hold a significant portion of the Collateral Ligament Stabilizer System market share during the forecast period.

The Medial Collateral Ligament (MCL) is a crucial ligament in the knee joint, connecting the femur to the tibia and resisting valgus forces. Injuries to the MCL are common, especially in contact sports like football, hockey, and skiing. The increasing prevalence of MCL injuries has led to a demand for Collateral Ligament Stabilizer Systems, designed to provide targeted support, reduce stress, and promote healing. As awareness of sports-related injuries increases and diagnostic techniques improve, the focus on MCL-specific stabilizers continues to drive market growth.

End User:-

Hospitals segment is the fastest-growing segment in Collateral Ligament Stabilizer System market share

The hospitals segment is the fastest-growing segment in the Collateral Ligament Stabilizer System market share and is expected to hold the market share over the forecast period.

Hospitals are key players in the Collateral Ligament Stabilizer System market, providing diagnosis, treatment, and rehabilitation for ligament injuries. They use advanced imaging technologies and specialized orthopedic departments for early detection and management. Hospitals perform numerous surgical procedures, particularly in severe ligament tears requiring post-operative support. The presence of skilled healthcare professionals and comprehensive rehabilitation programs drives the adoption of advanced stabilizer systems. The growing number of sports injury cases and improvements in hospital infrastructure further contribute to the market's growth.

Geographical Analysis

North America is expected to hold a significant position in the Collateral Ligament Stabilizer System market share

North America holds a substantial position in the Collateral Ligament Stabilizer System market and is expected to hold most of the market share due to high sports-related injuries and increasing orthopedic procedures. The region's strong sports culture, advanced medical technologies, and awareness about injury management contribute to market growth. Favourable reimbursement policies, extensive research and development activities, and key market players further accelerate the adoption of advanced stabilizer systems in the region. The region's well-established healthcare infrastructure and advanced medical technologies further drive market growth.

For instance, according to The Johns Hopkins Hospital, and Johns Hopkins Health System, over 3.5 million children aged 14 and younger are injured annually in sports or recreational activities, with brain injuries being the leading cause of death. Sports and recreational activities contribute to 21% of all traumatic brain injuries among American children. Almost 50% of head injuries in sports or recreational activities occur during incidents like bicycling, skateboarding, or skating. Over 775,000 children are treated for sports-related injuries annually, primarily due to falls, object strikes, collisions, and overexertion during unorganized or informal sports activities.

Europe is growing at the fastest pace in the Collateral Ligament Stabilizer System market

Europe holds the fastest pace in the Collateral Ligament Stabilizer System market and is expected to hold most of the market share is due to the growing focus on sports injury prevention and rehabilitation, orthopedic care advancements, and the popularity of activities like soccer, skiing, and rugby. Strong healthcare policies, government initiatives, and access to innovative medical devices like CE marking contribute to market growth. The aging population and collaborations between research institutions and medical device companies further support the market expansion across Europe.

For instance, according to The Johns Hopkins Hospital Sports injuries in the UK are prevalent, with around 2 million people visiting Accident & Emergency departments annually due to these injuries, resulting from various activities such as team sports like football and rugby, as well as individual physical activities like running and gym workouts.

Competitive Landscape

The major global players in the Collateral Ligament Stabilizer System market include Bauerfeind, Enovis (DJO Global, Inc.), DeRoyal Industries, Ossur hf, DARCO International, Inc., Orthofix US LLC (Breg, Inc.), Thuasne USA, Bio Dynamic Technologies, BSN Medical and among others.

Key Developments

  • In January 2024, Enovis has acquired Limacorporate, a company specializing in orthopedic implants, thereby strengthening its market dominance in the rapidly growing extremities market segment, with the acquisition of Limacorporate's 3D-printed Trabecular Titanium implants.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global Collateral Ligament Stabilizer System market report delivers a detailed analysis with 61 key tables, more than 59 visually impactful figures, and 210 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Ligament Type & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Ligament Type
  • 3.2. Snippet by Injury Type
  • 3.3. Snippet by End User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Prevalence of Sports-related Injuries
    • 4.1.2. Restraints
      • 4.1.2.1. Limited Awareness and Delayed Diagnosis in Emerging Regions
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. By Ligament Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Ligament Type
    • 6.1.2. Market Attractiveness Index, By Ligament Type
  • 6.2. Medial Collateral Ligament (MCL)*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Lateral Collateral Ligament (LCL)

7. By Injury Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Injury Type
    • 7.1.2. Market Attractiveness Index, By Injury Type
  • 7.2. Grade I (Mild)*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Grade II (Moderate)
  • 7.4. Grade III (Severe)

8. By End User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 8.1.2. Market Attractiveness Index, By End User
  • 8.2. Hospitals*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Orthopedic Clinics
  • 8.4. Others

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Ligament Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Injury Type
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.6.1. U.S.
      • 9.2.6.2. Canada
      • 9.2.6.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Ligament Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Injury Type
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.6.1. Germany
      • 9.3.6.2. U.K.
      • 9.3.6.3. France
      • 9.3.6.4. Spain
      • 9.3.6.5. Italy
      • 9.3.6.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Ligament Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Injury Type
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.6.1. Brazil
      • 9.4.6.2. Argentina
      • 9.4.6.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Ligament Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Injury Type
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.6.1. China
      • 9.5.6.2. India
      • 9.5.6.3. Japan
      • 9.5.6.4. South Korea
      • 9.5.6.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Ligament Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Injury Type
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

Key Market Players

  • 11.1. Bauerfeind.*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio
      • 11.1.2.1. Product Description
      • 11.1.2.2. Product Key Performance Indicators (KPIs)
      • 11.1.2.3. Historic and Forecasted Product Sales
      • 11.1.2.4. Product Sales Volume
    • 11.1.3. Financial Overview
      • 11.1.3.1. Company Revenue's
      • 11.1.3.2. Geographical Revenue Shares
      • 11.1.3.3. Revenue Forecasts
    • 11.1.4. Key Developments
      • 11.1.4.1. Mergers & Acquisitions
      • 11.1.4.2. Key Product Development Activities
      • 11.1.4.3. Regulatory Approvals etc.
    • 11.1.5. SWOT Analysis
  • 11.2. Enovis (DJO Global, Inc.)
  • 11.3. DeRoyal Industries
  • 11.4. Ossur hf.
  • 11.5. DARCO International, Inc.
  • 11.6. Orthofix US LLC (Breg, Inc.)
  • 11.7. Thuasne USA
  • 11.8. Bio Dynamic Technologies
  • 11.9. BSN Medical
  • Similar data will be provided for each market player.

Emerging Market Players

  • 11.10. Breg, Inc*
    • 11.10.1. Pipeline Products Description
    • 11.10.2. Product Key Performance Indicators (KPIs)
    • 11.10.3. Key Activities
    • 11.10.4. Market Entry Timelines
    • 11.10.5. Product Penetration Rate
    • 11.10.6. Sales Estimation and Projections
  • 11.11. Corin Group
  • Similar data will be provided for each market player.

LIST NOT EXHAUSTIVE

12. Appendix

  • 12.1 About Us and Services
  • 12.2 Contact Us